The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis

Table 1

Laboratory parameters in the study population.

Subjects’ characteristics	Healthy controls		Rheumatoid patients
	Premenopausal control (1)	Postmenopausal control (2)	Premenopausal patient (3)	Postmenopausal patient (4)
ESR (mm/h)	^b^,c	^d^,e
CRP (mg/L)	^b^,c	^d^,e
Fibrinogen (g/L)	^b	^d
Cholesterol (mmol/L)	^a	^d	^f
Triglycerides (mmol/L)		1.4 (0.7–3.9)	1.4 (0.7–3.3)
HDL (mmol/L)		1.6 (1.2–2.5)^d	1.3 (1.1–2.0)
LDL (mmol/L)	^a	^d^,e

The values are expressed as or median (range). ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; HDL: high-density lipoprotein; LDL: low-density lipoprotein; statistical significance (); statistical significance (). Statistical significance between groups are as follows: ^a1 and 2; ^b1 and 3;^c1 and 4; ^d2 and 3; ^e2 and 4; ^f3 and 4. Detailed laboratory parameters and clinical characteristics of the study population in the followed subgroups are presented in our previous work [11].